WOCKPHARMA Wockhardt Ltd Investments/Divestments Announcement 2024 - Antibiotic trial update WOCKHARDT LTD shares Zidebactam/Cefepime Phase III Clinical trial update, with 100% clinical cure rate in 30 patients with XDR infections under compassionate use, India-discovered antibiotic used successfully in challenging cases..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Wockhardt Ltd